B
bekeero
Guest
Some of the papers/abstracts that will be discussed are very interesting, including one based on this wounding related study co-authored by Dr. Luis Garza. Also interesting for our purposes is one in which Samumed’s Dr. Yusuf Yazici is a co-author. The title of this one is: “A small molecule modulator of the wnt pathway (SM04554) as a potential topical treatment for androgenetic alopecia (Androgenetic Alopecia)“.
Alcaris Therapeutics and their CEO Neal Walker are also present in a big way, both as sponsors and via leading a symposium on JAK inhibitors with many expert speakers. Hopefully someone asks them about their male pattern hair loss trials too since the symposium focuses on alopecia areate, scarring alopecia, pruritus and vitiligo. Dr. Christiano and Dr. Etienne Wang are also presenting a paper titled “Conditional ablation of JAK-STAT5 signaling induces anagen hair growth“
Alcaris Therapeutics and their CEO Neal Walker are also present in a big way, both as sponsors and via leading a symposium on JAK inhibitors with many expert speakers. Hopefully someone asks them about their male pattern hair loss trials too since the symposium focuses on alopecia areate, scarring alopecia, pruritus and vitiligo. Dr. Christiano and Dr. Etienne Wang are also presenting a paper titled “Conditional ablation of JAK-STAT5 signaling induces anagen hair growth“